These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11023040)

  • 1. Sex differences in relation to serum hepatitis B e antigen and alanine aminotransferase levels among asymptomatic hepatitis B surface antigen carriers.
    Tsai JF; Chuang LY; Jeng JE; Ho MS; Lin ZY; Hsieh MY; Wang LY; Tsai JH
    J Gastroenterol; 2000; 35(9):690-5. PubMed ID: 11023040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers.
    Chu CM; Sheen IS; Lin SM; Liaw YF
    Clin Infect Dis; 1993 May; 16(5):709-13. PubMed ID: 8507764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
    Tai DI; Lin SM; Sheen IS; Chu CM; Lin DY; Liaw YF
    Hepatology; 2009 Jun; 49(6):1859-67. PubMed ID: 19378345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.
    Lin CL; Liao LY; Liu CJ; Yu MW; Chen PJ; Lai MY; Chen DS; Kao JH
    Hepatology; 2007 May; 45(5):1193-8. PubMed ID: 17464993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive effect of serial serum alanine aminotransferase levels on spontaneous HBeAg seroconversion in chronic genotype B and C HBV-infected children.
    Wu JF; Su YR; Chen CH; Chen HL; Ni YH; Hsu HY; Wang JL; Chang MH
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):97-100. PubMed ID: 21716132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients.
    Ha M; Xia W; Tang D; Wu J; Sun L; Shen W; Huang Z; Chen X; Shan W
    Obes Res Clin Pract; 2016; 10(6):673-679. PubMed ID: 26515918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
    Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
    World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Hsu CA; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.
    Nakazawa T; Shibuya A; Takeuchi A; Shibata Y; Hidaka H; Okuwaki Y; Takada J; Tanaka Y; Watanabe M; Minamino T; Sakurai K; Koizumi W
    J Viral Hepat; 2011 Jul; 18(7):e191-9. PubMed ID: 21692932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].
    Zhou HJ; Li SG; Wen FY; Yang XY; Wu JL; Tan B; Fu J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.
    Peng CY; Hsieh TC; Hsieh TY; Tseng KC; Lin CL; Su TH; Tseng TC; Lin HH; Wang CC; Kao JH
    J Formos Med Assoc; 2015 Apr; 114(4):308-13. PubMed ID: 24315616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection.
    Tseng YR; Wu JF; Ni YH; Chen HL; Chen CC; Wen WH; Hsu HY; Chang MH
    Liver Int; 2011 Oct; 31(9):1373-80. PubMed ID: 21745315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection.
    Günal Ö; Barut Ş; Etikan İ; Duygu F; Tuncel U; Sünbül M
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():142-6. PubMed ID: 25910293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.